ARTICLE SYNOPSIS...Buying a share and holding forever can be an advantage, but do watch out for a correction.
ARTICLE SYNOPSIS...Has Avigen peaked? The stock gained after an advisory committee of the U.S. National Institute of Health stated it would recommend the initiation of human clinical trials for Avigen's AV201, a gene therapy for advanced Parkinson's disease.
ARTICLE SYNOPSIS...When Nortel broke out of its consolidation triangle (see "Nortel, Something To Look At?" December 23, 2003), the profits that were made on a buy signal were excellent. Is Lucent now offering the same opportunity?
ARTICLE SYNOPSIS...Is it cheaper to buy online or is it the hits on the ads feeding the company? Whatever it is, this is a company worth watching.